http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113667745-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e845733bd5a745639f7b4c00c32c027b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 |
| filingDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49dc965cf61b1203c2ad230d685d6bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ef87a39a3802489a81aece09c06286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f99abfbfc2fd21a75ca74497c33355b0 |
| publicationDate | 2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113667745-A |
| titleOfInvention | A gene polymorphism detection kit for predicting the efficacy of tumor necrosis factor alpha inhibitor and its detection method and application |
| abstract | The invention discloses a gene polymorphism detection kit for predicting the efficacy of a tumor necrosis factor alpha inhibitor, a detection method and application thereof, wherein the drug efficacy of the tumor necrosis factor alpha inhibitor is detected by detecting the TNFαG308A gene polymorphism To reflect the metabolic capacity, the kit designs specific amplification primers and sequencing primers for the polymorphism of TNFαG308A, and the kit includes the following components: sample treatment solution, magnetic beads, amplification reagent 1, amplification reagent 2 , TNFαG308A sequencing primer and positive control. On the one hand, the present invention adopts the method of extracting and amplifying the same tube, avoiding the risk of multiple pipetting and nucleic acid loss; on the other hand, rapid isothermal amplification is performed by adding anti-inhibitors; In order to detect the gene polymorphism of the efficacy of tumor necrosis factor alpha inhibitor in combination, and to give genetic advice for clinical personalized medicine. |
| priorityDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.